Vertex Pharmaceuticals
VRTX
#143
Rank
A$192.59 B
Marketcap
$750.03
Share price
1.82%
Change (1 day)
16.85%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2024 (TTM): A$0.53 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are A$11.02 Billion. a decrease over its 2023 earnings that were of A$6.90 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 A$0.43 B-93.69%
2023 A$6.90 B3.19%
2022 A$6.69 B53.56%
2021 A$4.35 B-12.06%
2020 A$4.95 B118.45%
2019 A$2.26 B120.64%
2018 A$1.02 B1473.64%
2017 A$65.36 M197.6%
2016 A$21.96 M-102.97%
2015 -A$0.74 Billion-28.46%
2014 -A$1.04 Billion-51.5%
2013 -A$2.14 Billion-30584.68%
2012 A$6.99 M-95.47%
2011 A$0.15 B
2009 -A$0.93 Billion
2007 -A$0.65 Billion83.1%
2006 -A$0.36 Billion59.02%
2005 -A$0.23 Billion3.28%
2004 -A$0.22 Billion-38.16%
2003 -A$0.35 Billion
2000 -A$59.41 Million-20.38%
1999 -A$74.61 Million31.62%
1998 -A$56.69 Million91.05%
1997 -A$29.67 Million-36.24%
1996 -A$46.54 Million12.45%
1995 -A$41.38 Million27.4%
1994 -A$32.48 Million-1833.33%
1993 A$1.87 M-112.12%
1992 -A$15.46 Million175%
1991 -A$5.63 Million-12.2%
1990 -A$6.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$0.27 B-36.94%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.23 B 2,478.65%๐Ÿ‡บ๐Ÿ‡ธ USA
A$23.38 B 5,264.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$13.09 Billion-3,102.15%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.23 B 6,149.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.16 Billion-134.76%๐Ÿ‡บ๐Ÿ‡ธ USA